Operational impact of COVID-19

November 6, Friday

The impact of COVID-19 on Recipharm’s worldwide operations is constantly monitored and regular updates provided on www.recipharm.com

We are pleased to report that currently, our operations are largely functioning in a normal manner albeit with enhanced safety procedures and adapted working practices.

Recipharm’s response to COVID-19

We have invested significant effort and resources to ensure continued supply to our customers and patients. This includes adapting work schedules, shifts patterns and overtime work along with employing new work methods.  Other measures include the minimisation of employee travel, supporting home working and enhanced health and safety protocols in in all our operations.

Recipharm continues to follow all governmental recommendations whilst at the same time working to mitigate any disruptions. Our highest priority is always to ensure that we uphold our responsibilities to employees, customers, patients and partners. This means striving to deliver the highest quality of service whilst also focusing on the safety and well-being of our workforce and extended community. 

We are very grateful to our employees and partners who continue to willingly support our efforts to maintain operations and our supply chains. 

Contact information

Erik Haeffler, Vice President Manufacturing Services & Head of Sustainability, erik.haeffler@recipharm.com, + 46 8 602 52 85